Zyprexa: Aggressive Marketing Poster Child

Zyprexa has been approved by the FDA for schizophrenia and bipolar disorder. Yet, the Eli Lilly drug has been used for “off label” issues since it first was introduced. This is a direct result of Eli Lilly’s overly aggressive marketing campaign. The pharmaceutical company has made a ton of money on Zyprexa at the expense of the consumer, so much that it can afford lawsuits and still turn a handsome profit. Lilly has done its homework. What’s a few nuisance lawsuits when it’s hauling in $13 billion in sales. So what if patients are likely to develop diabetes. It’s all about the profits.